AZO
AutoZone, Inc.
There isn't enough reported data to score AZO yet.
BABA
Alibaba Group Holding Limited
BABA's fundamentals are weak: its operating margin fell 10 points to 4.2% and free cash flow turned negative, though revenue grew 4.3%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
AZO Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| Unavailable | |
| Unavailable |
AZO's profitability is currently healthy. There isn't enough data to rate its revenue, cash flow and balance sheet.
BABA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Healthy |
BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
AZO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 18x | $2,715 | -17% |
| Fair | 20x | $3,032 | -6.8% |
| Current | 21x | $3,252 | — |
| Expensive | 23x | $3,547 | +9.1% |
Historical ranges are pointers, not guarantees.
AZO has the edge over BABA in the historical PE scenario, which offers more potential upside but is not a forecast.
BABA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $69.66 | -26% |
| Fair | 20x | $86.59 | -8.2% |
| Current | 21x | $94.36 | — |
| Expensive | 26x | $115 | +22% |
Historical ranges are pointers, not guarantees.
BABA's PE is 21x, but its earnings don't support one, so it isn't a reliable read right now.
AZO Forward outlook
There aren't enough analyst estimates for AZO to show an outlook.
BABA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for BABA, with profitability improving. However, they disagree widely on these estimates.
AZO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $152.55 | +5.3% |
| Q2 2026 | $145.44 | -1.5% |
| Q1 2026 | $142.73 | -4.2% |
| Q4 2025 | $143.39 | -4.1% |
| Q3 2025 | $144.87 | -3.1% |
| Q2 2025 | $147.59 | +2.3% |
| Q1 2025 | $148.92 | +5.1% |
| Q4 2024 | $149.52 | +8.8% |
AZO earned $152.55 per share over the past year, up 5.3% from the year before.
BABA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $4.42 | -52% |
| Q1 2026 | $6.57 | -18% |
| Q4 2025 | $5.79 | -22% |
| Q3 2025 | $7.85 | +49% |
| Q2 2025 | $9.27 | +116% |
| Q1 2025 | $8.06 | +71% |
| Q4 2024 | $7.47 | +24% |
| Q3 2024 | $5.26 | -35% |
BABA has the edge over AZO on earnings, with stronger typical year-over-year growth.
AZO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $4.8B | +8.4% |
| Q1 2026 | $4.3B | +8.1% |
| Q4 2025 | $4.6B | +8.2% |
| Q2 2025 | $4.5B | +5.4% |
| Q1 2025 | $4B | +2.4% |
| Q4 2024 | $4.3B | +2.1% |
| Q3 2024 | $6.2B | +9% |
| Q2 2024 | $4.2B | +3.5% |
AZO has the stronger quarterly revenue trend. Revenue is up 22% for AZO versus up 8.3% for BABA.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 19% | -0.3 points |
| Q1 2026 | 16% | -1.5 points |
| Q4 2025 | 17% | -2.7 points |
| Q2 2025 | 19% | -1.9 points |
| Q1 2025 | 18% | -1.4 points |
| Q4 2024 | 20% | -0.6 points |
| Q3 2024 | 21% | -0.6 points |
| Q2 2024 | 21% | +0.3 points |
AZO has the edge over BABA on profitability, with a higher operating margin.
BABA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.2B | +8.3% |
| Q1 2026 | $36.5B | +2.9% |
| Q4 2025 | $42.7B | +1.7% |
| Q3 2025 | $37.2B | +4.8% |
| Q2 2025 | $37.2B | +1.8% |
| Q1 2025 | $35.5B | +6.6% |
| Q4 2024 | $42B | +7.6% |
| Q3 2024 | $35.5B | +5.2% |
BABA's revenue has grown year over year for 16 quarters in a row: $40.2B last quarter, up 8.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.2% | -6.9 points |
| Q1 2026 | -0.3% | -12 points |
| Q4 2025 | 7.1% | -7.6 points |
| Q3 2025 | 2.2% | -13 points |
| Q2 2025 | 14% | -0.7 points |
| Q1 2025 | 12% | +5.4 points |
| Q4 2024 | 15% | +6.1 points |
| Q3 2024 | 15% | 0 points |
BABA's operating margin was 7.2% last quarter, down 6.9 points from the same quarter a year ago.
AZO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $456.5M | +7.9% |
| Q1 2026 | $35.6M | -88% |
| Q4 2025 | $630M | +12% |
| Q2 2025 | $423.1M | -2.6% |
| Q1 2025 | $291M | +63% |
| Q4 2024 | $564.8M | -5.1% |
| Q2 2024 | $434.4M | -22% |
| Q1 2024 | $178.7M | -15% |
AZO's free cash flow has been positive every quarter since late 2019: $1.5B over the past year, up 5.2% from the year before.
BABA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6.7B | -$4.1B |
| Q1 2026 | -$2.7B | +$1.5B |
| Q4 2025 | $1B | -90% |
| Q3 2025 | -$3.2B | -254% |
| Q2 2025 | -$2.7B | -182% |
| Q1 2025 | -$4.2B | -12231% |
| Q4 2024 | $10.4B | -4.8% |
| Q3 2024 | $2.1B | -62% |
BABA's free cash flow has turned negative after years in the green: −$11.6B over the past year.
AZO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +13K shares |
| 1 year | -2.2% | -380K shares |
| 3 years | -12% | -2.2M shares |
| 5 years | -26% | -5.9M shares |
| Available history | -31% | -7.6M shares |
AZO has the edge over BABA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $580.7M |
| Q1 2026 | $314.5M |
| Q4 2025 | $427.2M |
| Q2 2025 | $268.8M |
| Q1 2025 | $326.4M |
| Q4 2024 | $540.1M |
| Q2 2024 | $728.1M |
| Q1 2024 | $222.2M |
BABA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +11.1M shares |
| 1 year | +0.9% | +21.4M shares |
| 3 years | -6.2% | -161M shares |
| 5 years | -12% | -339M shares |
| Available history | -8.4% | -221M shares |
BABA has 2.4B diluted shares, up 0.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $269.8M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BABA spent $270M buying back its own shares over the past year, after none the year before.
AZO Net Leverage
BABA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.2x | Net Cash |
BABA's net debt is less than a year of its operating earnings (EBITDA).
AZO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.9 | Neutral |
| Stochastic | 80.2 | Overbought |
AZO's weekly RSI is 56 (neutral) and its Stochastic is 80 (overbought).
BABA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 12.7 | Oversold |
BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).
AZO PE vs Consumer Cyclical Sector
| Metric | AZO | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 18% above |
| PE % | 69 | 47 | 22 pts above |
AZO has the edge over BABA on valuation relative to its sector.
BABA PE vs Consumer Cyclical Sector
| Metric | BABA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 60 | 47 | 13 pts above |
BABA is trading at 21x earnings, a 19% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
AZO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3,070.5 | 5.9% above |
| 20 week MA | $3,030.2 | 7.3% above |
| 50 week MA | $3,287.4 | 1.1% below |
| 100 week MA | $3,508.3 | 7.3% below |
| 200 week MA | $3,135.5 | 3.7% above |
AZO has the edge over BABA on trend strength, trading above more of its moving averages.
BABA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $104.7 | 9.9% below |
| 20 week MA | $111.1 | 15% below |
| 50 week MA | $128.0 | 26% below |
| 100 week MA | $127.7 | 26% below |
| 200 week MA | $106.4 | 11% below |
BABA is in a downtrend: it's below all five of its weekly moving averages, and 11% below its 200-week average.
AZO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1,202.6 | $1,204.2 | +0.1% |
| 2021 | $1,204.2 | $2,014.5 | +67% |
| 2022 | $2,014.5 | $2,430.7 | +21% |
| 2023 | $2,430.7 | $2,585.6 | +6.4% |
| 2024 | $2,585.6 | $3,241.6 | +25% |
| 2025 | $3,241.6 | $3,448.7 | +6.4% |
| 2026 YTD | $3,448.7 | $3,252.2 | -5.7% |
AZO has the edge over BABA on returns for 2026, with the stronger performance.
BABA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $215.5 | $222.0 | +3% |
| 2021 | $222.0 | $118.7 | -47% |
| 2022 | $118.7 | $85.7 | -28% |
| 2023 | $85.7 | $77.5 | -9.5% |
| 2024 | $77.5 | $85.1 | +9.7% |
| 2025 | $85.1 | $152.2 | +79% |
| 2026 YTD | $152.2 | $94.4 | -38% |
BABA has finished lower in three of the last six years. It's down 38% so far in 2026.